Archive for the ‘pharmaceuticals’ Tag

New drugs. Cheaper drugs. Why not both?

3/15/23, The Indicator (8:55)

Link: https://www.npr.org/2023/03/15/1163748730/new-drugs-cheaper-drugs-why-not-both

Teaching Ideas

Summary: The Inflation Reduction Act allows Medicare to negotiate the price of some drugs. What if this happened at a larger scale? The dismal answer would be “less incentive for pharma to innovate.” Yes, there is no such thing as a free lunch, but what about a cheaper lunch? The Indicator offers an optimistic view and our classroom exercise analyzes these policy ideas that may offer a solution to this “knotty” dilemma between prices and new drugs.

Posted March 16, 2023 by ishanitewari in Government, Incentives, THE INDICATOR

Tagged with , , ,

FTC fights against new strategy for delaying generics   Leave a comment

NORWICH, CT - MARCH 23: Oxycodone pain pills prescribed for a patient with chronic pain lie on display on March 23, 2016 in Norwich, CT. Communities nationwide are struggling with the unprecidented opioid pain pill and heroin addiction epidemic. On March 15, the U.S. Centers for Disease Control (CDC), announced guidelines for doctors to reduce the amount of opioid painkillers prescribed, in an effort to curb the epidemic. The CDC estimates that most new heroin addicts first became hooked on prescription pain medication before graduating to heroin, which is stronger and cheaper. (Photo by John Moore/Getty Images)

Link: http://www.marketplace.org/2016/03/31/health-care/ftc-fights-against-new-strategy-delaying-generics

Summary: The Federal Trade Commission (FTC) has brought an important case against ‘pay-for-delay schemes’, seeking to show that non-monetary deals between pharmaceutical companies inhibit the market from functioning properly. More importantly, they seek to demonstrate that these deals are illegal.

Original Air Date: April 1, 2016

Length: 2 minutes 10 seconds

Posted September 14, 2016 by cherokeebelval in Ethics, Government, Health economics, Market structure, Monopoly, Perfect competition, Regulation, short length

Tagged with , ,